Marksans Pharma Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Key Metrics
PE ratio
21.54
PB ratio
2.88
Dividend yield
0.46%
Beta
1.04
Market cap
₹77.51B
Enterprise value
₹75.61B
Company profile
| Industry / Sector | Drug Manufacturers - General / Healthcare |
|---|---|
| Full time employees | 1840 |
| Website | https://marksanspharma.com |
| Mailing address | Grandeur 11th Floor Veera Desai Extension Road Oshiwara, Andheri (West) Mumbai 400053 India |
| Phone / Fax | 91 22 4001 2000 / 91 22 4001 2011 |
Dividends
Dividend yield
0.46%
Dividend amount
₹0.80
Payout ratio
10.06%
5Y Avg. yield
-%
Marksans Pharma Limited paid ₹0.80 dividend and the ex-dividend date was 01 Aug 2025.The dividend payout ratio is 10.06%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MARKSANS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Marksans Pharma Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Mark B. Saldanha | Non-Independent Executive Chairman & MD | 53 | |
| Mr. Jitendra M. Sharma | Group Chief Financial Officer | 56 | |
| Mr. Harshavardhan Panigrahi | Company Secretary, Manager of Legal & Compliance Officer | ||
| Ms. Sandra Saldanha | Whole-Time Executive Non Independent Director | 54 | |
| Mr. Varddhman Vikramaditya Jain | Whole-Time Executive Non Independent Director | 55 | |
| Mr. Vishal Bhargava | Director Operations | 54 | |
| Mr. David Mohammed | Managing Director of Australia Operations | ||
| Mr. Sunil K. Rane | Senior Vice President of QC | 56 | |
| Mr. Sathish Kumar | Managing Director of UK Operations | ||
| Mr. Anjani Kumar | Chief Operating Officer of US Operations | 64 |
Profitability and management effectiveness
Profit margin
12.85%
Operating margin
18.08%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Marksans Pharma Limited is 77.51B and its enterprise value is 75.61B. The enterprise value to revenue ratio of MARKSANS is 2.70. The enterprise value to EBITDA ratio of MARKSANS is 15.36.
The MARKSANS's stocks Beta value is 1.04 making it 4% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Marksans Pharma Limited (NSE:MARKSANS) Frequently Asked Questions
1. What is Marksans Pharma Limited's Stock Symbol?
Marksans Pharma Limited trades on NSE under the ticker symbol "MARKSANS".
2. What is Marksans Pharma Limited's stock price today?
One share of MARKSANS stock can currently be purchased for approximately ₹171.05.
3. How can I contact Marksans Pharma Limited?
Marksans Pharma Limited's mailing address is Grandeur 11th Floor Veera Desai Extension Road Oshiwara, Andheri (West) Mumbai 400053 India. The company can be reached via phone at 91 22 4001 2000.
4. What is Marksans Pharma Limited's official website?
The official website of Marksans Pharma Limited is https://marksanspharma.com.